The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle
- PMID: 8076800
- DOI: 10.1111/j.1574-6968.1994.tb07041.x
The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle
Abstract
The development of natural antibodies to Lactococcus lactis in three inbred strains of mice and the effect of inoculating L. lactis into these mice has been investigated. All animals developed detectable levels of natural (systemic and secretory) anti-lactococcal antibodies. Systemic anti-lactococcal antibodies were principally IgG in young mice. An increase in anti-lactococcal IgM occurred in all older animals. Inoculation of L. lactis strains MG1820 or MG1363 by the oral and parenteral routes induced systemic anti-lactococcal antibody responses in a dose-dependent fashion. The relative immunogenicity of individual bacterial proteins varied according to mouse strain and route of inoculation.
Similar articles
-
The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.Vaccine. 2015 Mar 24;33(13):1586-95. doi: 10.1016/j.vaccine.2015.02.006. Epub 2015 Feb 16. Vaccine. 2015. PMID: 25698490
-
Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.Mol Cell Probes. 2014 Feb;28(1):25-30. doi: 10.1016/j.mcp.2013.08.003. Epub 2013 Sep 13. Mol Cell Probes. 2014. PMID: 24036137
-
Oral administration of Lactococcus lactis expressing Helicobacter pylori Cag7-ct383 protein induces systemic anti-Cag7 immune response in mice.FEMS Immunol Med Microbiol. 2009 Dec;57(3):257-68. doi: 10.1111/j.1574-695X.2009.00605.x. Epub 2009 Sep 1. FEMS Immunol Med Microbiol. 2009. PMID: 19807786 Free PMC article.
-
Lactococcus lactis-based vaccines: current status and future perspectives.Hum Vaccin. 2011 Jan 1;7(1):106-9. doi: 10.4161/hv.7.1.13631. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21263226 Review.
-
[Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].Wei Sheng Wu Xue Bao. 2006 Aug;46(4):680-3. Wei Sheng Wu Xue Bao. 2006. PMID: 17037080 Review. Chinese.
Cited by
-
Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations.Vaccine. 2006 May 1;24(18):3900-8. doi: 10.1016/j.vaccine.2006.02.040. Epub 2006 Mar 2. Vaccine. 2006. PMID: 16545511 Free PMC article.
-
Mucosal Vaccination with Lactococcus lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B Streptococcus in a Murine Model.Vaccines (Basel). 2020 Mar 26;8(2):146. doi: 10.3390/vaccines8020146. Vaccines (Basel). 2020. PMID: 32224855 Free PMC article.
-
Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system.Folia Microbiol (Praha). 1995;40(3):225-30. doi: 10.1007/BF02814197. Folia Microbiol (Praha). 1995. PMID: 8919927 Review.
-
Effect of treatment with Lactococcus lactis NZ9000 on intestinal microbiota and mucosal immune responses against Clostridium perfringens in broiler chickens.Front Microbiol. 2023 Dec 18;14:1257819. doi: 10.3389/fmicb.2023.1257819. eCollection 2023. Front Microbiol. 2023. PMID: 38164397 Free PMC article.
-
Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis.Microb Cell Fact. 2006 Mar 23;5:14. doi: 10.1186/1475-2859-5-14. Microb Cell Fact. 2006. PMID: 16556312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources